Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$7.12 - $20.24 $22 Million - $62.4 Million
-3,083,427 Reduced 76.13%
966,573 $19.3 Million
Q2 2022

Aug 12, 2022

BUY
$5.1 - $10.0 $12.2 Million - $23.9 Million
2,390,294 Added 144.02%
4,050,000 $27.9 Million
Q1 2022

May 16, 2022

BUY
$8.34 - $14.69 $13.8 Million - $24.4 Million
1,659,706 New
1,659,706 $15.4 Million

Others Institutions Holding FMTX

About Forma Therapeutics Holdings, Inc.


  • Ticker FMTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,860,400
  • Market Cap $958M
  • Description
  • Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...
More about FMTX
Track This Portfolio

Track Deep Track Capital, LP Portfolio

Follow Deep Track Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deep Track Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Deep Track Capital, LP with notifications on news.